Genitourinary Cancer Research Studies
RENAL CELL
ACCRU-GU-1703: Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First Line Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC).
S1500: A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib, Crizotinib, Savolitinib, and Sunitinib) in Metastatic Papillary Renal Carcinoma (PAPMET).
BLADDER
A031501: Phase III randomized "Adjuvant study of MK-3475 (pembrolizumab) in muScle invaSive and locally ADvanced urOthelial caRcinoma" (AMBASSADOR) versus observation.
PROSTATE
GU003: A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) versus Conventional Post-Prostatectomy Radiation Therapy (COPORT).